RIGL   $26.04  3.99% Market Closed After Close 26.04 0.0

Rigel Pharmaceuticals Inc
Total Cash 49.10M
totalCashPerShare 2.791
EBITDA -7.52M
Total Debt 100.31M
quickRatio 1.33
currentRatio 1.615
Total Revenue 130.20M
debtToEquity
Revenue/Share 7.446
ROA -0.046430003
ROE
grossProfits
freeCashflow 11.18M
operatingCashflow -12.31M
earningsGrowth
revenueGrowth 0.423
grossMargins 0.76101
ebitdaMargins -0.05776
operatingMargins 0.012130001
profitMargins -0.10931
enterpriseValue 306.34M
forwardPE 23.148438
floatShares 14.73M
sharesOutstanding 17.59M
sharesShort 717.99K
sharesShortPriorMonth 500.47K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.62%
Short Ratio help_outline 3.48%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -1.7
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -14.23M
trailingEps -0.77%
forwardEps 0.64%
enterpriseToEbitda -40.74
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.06 3Q 2024
institutionsCount 129
lastUpdated Nov. 6, 2024, 7:24 p.m.